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Abstract
Background: There is a growing interest to use health status or disease control questionnaires in routine clinical
practice. However, the validity of most questionnaires is established using techniques developed for group level
validation. This study examines a new method, using patient interviews, to validate a short health status
questionnaire, the Clinical COPD Questionnaire (CCQ), at the individual patient level.
Methods: Patients with COPD who visited an outpatient clinic completed the CCQ before the consultation, and
the specialist physician completed it after the consultation. After the consultation all patients had a semi-structured
in-depth interview. The patients’ CCQ scores were compared with those of the treating clinician, and with mean
scores from 5 clinicians from a pool of 20 who scored the CCQ after reading the transcript of the in-depth
interviews only. Agreement was assessed using Lin’s concordance correlation coefficient (CCC), and Blant and
Altman plots. Interviews with patients with low agreement were reviewed for possible explanations.
Results: A total of 44 COPD patients (32 male, mean age 66 years, FEV1 45% of predicted) participated. Agreement
between the patients’ CCQ scores and those of the treating clinicians (CCC = 0.87) and the mean score of the
reviewing clinicians (CCC = 0.86) was very high. No systematic error was detected. No explanation for individuals
with low agreement was found.
Conclusion: The validity of the CCQ on the individual patient level, as assessed by these methods, is good.
Individual health status assessment with the CCQ is therefore sufficiently accurate to be used in routine clinical
practice.
Background
Health status measurement by questionnaires can be
used in routine clinical practice to enhance communica-
tion, monitor disease progression and response to treat-
ment, screen for undetected disability, improve patient
satisfaction, and assess disease severity [1,2]. Question-
naires available for use in routine clinical practice must
be short, and easy to administer, score and interpret; in
addition, guidelines for their interpretation should be
available [3,4]. Questionnaires should also be reliable
and validated for the patient who completes the
questionnaire.
Methods to develop and validate health status or qual-
ity of life questionnaires are well established. These vali-
dation processes focus on their use in clinical trials in
groups of patients. However, despite their increasing use
in everyday practice, we found only one proposed guide-
line for the validation of questionnaires in the individual
patient. In 1995 McHorney and Tarlov suggested a
number of measurement standards for individual patient
application of questionnaires, such as high internal con-
sistency reliability (above 0.9) and a small standard error
of measurement, besides usual qualities such as con-
struct validity and sensitivity to clinical change [3].
Although these proposed standards are mainly based on
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questionnaires have been validated for individual health
status assessment according to these standards [3].
Reliability levels of 0.90-0.95 are difficult to meet for
many existing questionnaires. Secondly, since reliability
is related to questionnaire length and measuring a uni-
dimensional construct, newly developed questionnaires
aiming to achieve these levels of reliability should be
long and unidimensional (i.e. they measure only one
aspect of the disease). However, clinicians might be
more interested in being informed about several aspects
of the disease (e.g. emotions, functional state and symp-
toms) and may prefer short questionnaires. Therefore, it
may be interesting to ignore these suggested guidelines
and assess whether a questionnaire is valid according to
the dynamics of routine clinical practice.
To address this question we published a proposal for
a new methodology [5]. In this methodology the
patient’s health status in daily life (as measured by an
in-depth interview) is used as the gold standard, and
the outcome of the in-depth interview is compared with
the patient’s score on the questionnaire completed in
the clinic before the in-depth interview took place. We
applied this new methodology in patients with chronic
obstructive pulmonary disease (COPD), a condition that
has a large impact on health status [6], even in mild
disease [7].
One of the health status questionnaires used in COPD
in clinical trials and clinical practice is the Clinical
COPD Questionnaire (CCQ) [8]. This is a short 10-item
questionnaire with answers based on a 7-point Likert
scale. The final score is calculated by simply summing
the item scores and dividing them by the number of
items. The CCQ has three domains: symptoms
(4 items), mental health (2 items) and functional status
(4 items). The CCQ has shown to be reliable health sta-
tus measure, is responsive to treatment and is stable
over time if no changes occur [8,9].
This article describes the validation, at the individual
patient level, of the CCQ.
Methods
Patients
Patients with physician diagnosed COPD, and confirmed
by lung function measurement, visiting an outpatient
clinic were invited to participate in the study. Patients
were excluded if they had suffered a myocardial infarc-
tion within 3 months prior to enrolment. All patients
gave written informed consent.
Measurements
Lung function was taken from the patient’sc h a r t s ,
including height and weight. Exercise capacity was
assessed by the 6-min walking distance test performed
according to the ATS criteria [10]. Pulse oxygenation
and BORG scores for dyspnoea [11] were measured
before and after the walking test. Health status was
measured using the CCQ. Dyspnoea during exercise was
measured with the MRC dyspnoea score. The BODE
score (a multidimensional index) was calculated[12].
CCQ
The CCQ is a 10-item health status questionnaire mea-
suring symptoms, functional status and mental status in
patients with COPD. The questionnaire is self-adminis-
tered, and can be completed in 2 min. The CCQ has a
high internal consistency reliability (0.91 [8]) and a
small standard error of measurement (0.21 [13]) The
minimal clinically important difference (MCID) was cal-
culated using three different methods and is set at 0.4
points [13].
Study design
Patients completed the CCQ prior to the routine con-
sultation with their pulmonary clinician. Directly after
the consultation, the pulmonary clinician (without
knowledge of the patient’s scores) completed the CCQ
as he thought the patient should have completed the
CCQ. After the consultation, patients performed the
6-min walking distance test.
One of the investigators (SLS or BdV), who did not
know the patient, held a semi-structured in-depth indi-
vidual interview with the patients on the day of the con-
sultation. Patients were asked to comment on every
separate concept of the questionnaire. They were asked
what thoughts they had during completion of the indivi-
dual questions, and were asked to give examples of their
symptoms and disabilities in daily life.
Group of reviewing clinicians
All interviews were recorded and fully transcribed. All
references to scores on individual items of the question-
naire (in numbers or words) were covered by black bars
to blind these results for the reviewing clinicians.
Twenty sets were created containing: i) patient charac-
teristics: gender, age, marital status, forced expiratory
volume in one second (FEV1) %predicted, body mass
index, 6-min walking distance, oxygenation at start of
the 6-min walking distance, and the number of pack
years; ii) the transcribed and blinded interview; and iii) a
blank CCQ.
Each set of interviews contained 11 randomly assigned
interviews. The order in which interviews were in the
packaged set was randomised to prevent fatigue of the
reviewers and learning effects in the interviews per-
formed later in sequence.
These sets were sent to 20 pulmonary physicians and
general practitioners who have a special interest in
Kocks et al. Health and Quality of Life Outcomes 2010, 8:135
http://www.hqlo.com/content/8/1/135
Page 2 of 7pulmonary diseases. The clinicians were instructed to
complete the CCQ of a patient the way they thought
the patient should have rated the CCQ, based on the
patient characteristics and interview.
This method resulted in each patient/interview being
reviewed and scored by five separate clinicians.
Data processing
The agreement between patient CCQ scores and the
treating physician and reviewing clinicians scores was
presented in Blant and Altman plots. The Shapiro-Wilk
normality test was used to assess normality.
The pairwise agreement (concordance) between patient’s
score, treating clinician’s score and the mean of the scores
of the five reviewing clinicians, was studied by two coeffi-
cients: the intraclass correlation coefficient (ICC) and Lin’s
concordance correlation coefficient (CCC). Both range
from 0 = no agreement, to +1 = perfect agreement.
Lin et al. have proposed a unified approach for asses-
sing agreement for continuous and categorical data [14].
For the pairwise agreement used in our study, the uni-
fied estimate reduces to the original CCC proposed by
Lin [15]. The CCC contains a measurement of precision
and of accuracy for a better understanding of the
sources of disagreement.
The equation from Lin (1989) is
c
xy
xy
s
ss x y
=
++−
2
22 2 ()
where x and y are the mean values of the measures
at 2 times, by 2 raters, or by 2 methods. Lin further pro-
poses two absolute indices, the Total Deviation Index
(TDI) and the Coverage Probability (CP), which are
independent of the total data range. The MCID is used
for the Coverage Probability.
The cut-off points described for rating agreement
based on the ICC are ≤ 0.4 as poor to fair, 0.41-0.6 as
moderate, 0.61-0.8 as good, and 0.81-1.0 as excellent.
Because the CCC and ICC measure the same construct,
the cut-off points can be assumed to be similar.
A significance level of 0.05 was considered statistically
significant.
All analyses (excluding the CCC) were performed
using SPSS for windows version 14. The CCC was cal-
culated using SAS version 9.1 for Windows and the
macro available at http://tigger.uic.edu/~hedayat/
Results
A total of 44 patients participated in the study, in equal
numbers at the two locations. Most patients had severe
COPD. Table 1 presents the characteristics of the study
participants.
The relation between the patient’ss c o r e sa n dt h e
reviewer’s scores is shown in the Blant and Altman
plots (Figure 1). No systematic errors can be seen as
there is no trend visible. The Blant and Altman plots of
the separate domains show more deviation from the ori-
gin than the total score, where the functional status and
mental state have the largest deviation.
The Shapiro-Wilk normality test revealed that the
total scores of the patients, the treating clinicians and
the reviewing clinicians are normally distributed, guar-
anteeing correct confidence intervals. Table 2 shows
that the agreement between patients’ CCQ score and
the scores of the treating clinicians (CCC = 0.87) and
the mean score of five reviewing clinicians (CCC = 0.86)
was excellent. The agreement between the treating clini-
cians and reviewing clinicians was good (CCC = 0.74).
In all three cases the accuracy was considerably higher
than the precision. The CCQ scores of the patients were
within the limits of the MCID of the scores of the treat-
ing clinician in 62% and the mean score of the reviewing
clinicians in 63%. The proportion of cases within the
MCID of 0.4 (CP0.4) between treating clinician and
reviewing clinicians was lower (0.50).
There were no differences in patient characteristics
between patients with a score difference smaller than
the MCID, and those larger than the MCID between
patient and reviewing clinicians. No recurrent themes
emerged from the interviews to explain low agreement.
Discussion
This study uses a new method to assess the individual
validity of a health status questionnaire. The method
was applied in the management of COPD, with the
Clinical COPD Questionnaire (CCQ) health status ques-
tionnaire. This study shows that there is a very good
agreement in CCQ outcomes between the individual
patient score and 20 reviewing clinicians who did not
know the patient but scored the CCQ based on an in-
depth interview. In combination with the previously
known high reliability and stability, this confirms the
validity of the CCQ at the individual patient level.
This new method to assess the validity of health status
questionnaires in clinical practice is feasible for a short
questionnaire, but requires much effort due to the
patient interviews and the subsequent review by clini-
cians. However, by using transcripts of interviews with
each individual patient, this method provides accurate
and transparent information about the actual perfor-
mance of a patient who is asked to complete a question-
naire in daily clinical practice. The use of qualitative
methods to assess the individual accuracy of a question-
naire in routine practice provides more insight into indi-
vidual validity than pure statistical methods assessing
the internal consistency and stability of a questionnaire.
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been assessed [8,9,16,17]. In two of these studies inter-
nal stability and consistency was very high, thus meeting
the requirements for individual use of the questionnaire
[8,9]. However, in a recent study this high level was not
met [16], possibly due to the different study population
and methods used in that study. Nevertheless the high
concordance between the results of the approach
according to the standards as proposed by McHorney
and Tarlov [3] and our new method using patient inter-
views, confirms the acceptability of this new method.
The high CCC indicates that there was no systematic
error in measuring. The Blant and Altman plots also
confirm this finding. The absence of a systematic error
is in contrast to previous findings of a difference in
patient-proxy ratings of quality of life [18] and differ-
ences in patient-clinician ratings [19]. Proxies and clini-
cians tend to rate the quality of life worse than the
patients [18,20]. The domains of the questionnaires that
cover emotions tend to differ more between proxies and
patients than the domains measuring symptoms[18]. In
the current studies we also see that the mental state
domain shows the least concordance; however, there is
no systematic under- or over-estimation compared to
the patient’s score.
For the Bland and Altman plots we chose a difference
in scores of 0.4 (the MCID), as cut-off point for agree-
ment. Over 60% of the 44 patient-reviewer scores dif-
fered less than the MCID. Of the patients-reviewer
scores, 90% (the TDI0.9)w e r ew i t h i n0 . 7p o i n t s .W e
chose the MCID because this difference in score would
(according to the definition) potentially cause a clinician
to change the management: “the smallest difference in a
score in the domain of interest which patients perceive as
beneficial and which would mandate in the absence of
troublesome side-effects and excessive costs a change in
the patient’s management“ [21]. Compared to others, we
chose a very strict cut-off point. In Wilson’sm e t h o df o r
proxy ratings, a moderate difference is used [18]. For
the CCQ, this moderate difference would be around 1.3
[13], which is far more than the 0.7 points in which 90%
of scores were in the current study.
A limitation of this study is that this new method of
assessing the validity of a health status questionnaire on
the individual patient level could be improved by addi-
tional information about the individual patient’ss c o r i n g
stability and responsiveness to changes. The stability of
scoring of the studied population could be assessed using
the test-retest method. Although the test-retest reliability
of the CCQ was very high in two studies [8,9], and so
Table 1 Characteristics of the study population
Number (%) Mean (±SD) IQR (25th-75th)
Gender Male 32 (72.7)
Female 12 (27.3)
Age (years) 66.1 (7.4)
Marital status Married 33 (75.0)
Not Married 7 (15.9)
Divorced 1 (2.4)
Widow 3 (6.8)
Educational level No primary school 3 (6.8)
Primary school 10 (22.7)
High school 24 (54.5)
College/University 5 (11.4)
Missing 2 (4.5)
Pack years 29.3 * (15.7-46.8)
FEV1 % predicted 44.8 (13.8)
Tiffenau 41.2 11.1
GOLD stage I 0 (0.0)
II 13 (29.5)
III 26 (59.1)
IV 5 (11.4)
BODE score 2.9 (1.8)
CCQ Total score 2.2 (0.9)
Current exacerbation 5 (11.4)
IQR: Inter Quartile Range, FEV1: Forced Expiratory Flow in one second
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did not confirm this in the present group of patients.
The current study could not identify patient factors
that were associated with low agreement between
patient and reviewers. A possible explanation for low
agreement in some individuals might be that most
patients completed the questionnaire for the first time.
During the interview, patients sometimes answered “now
I’m re-thinking about this, my score would have been...”.
Although some patients with a low agreement gave the
impression of lower intelligence, this could not be sub-
stantiated by a lower educational level.
In the present study we found a better agreement in
scores between patients and the treating clinicians than
Figure 1 Blant and Altman plots showing the relationship between the scores of the patients and the reviewers. A: Clinical COPD
Questionnaire (CCQ) total score; B: CCQ symptoms domain score; C: CCQ functional status domain score; D: CCQ mental state domain score.
Table 2 Agreement between patient, treating clinician and reviewing clinicians
Agreement between: Statistics CCC Precision Accuracy TDI 0.9 CP 0.4
Patient & Treating clinician Estimate 0.87 0.88 0.98 0.7 0.62
95% Conf. Limit 0.79 0.81 0.94 0.9 0.53
Patient & Mean reviewing clinicians Estimate 0.86 0.87 0.99 0.7 0.63
95% Conf. Limit 0.79 0.80 0.94 0.9 0.54
Treating clinician & Mean reviewing clinicians Estimate 0.74 0.76 0.97 1.0 0.50
95% Conf. Limit 0.61 0.63 0.89 1.1 0.42
95% Conf. Limit: 95% confidence limit. CCC: concordance Correlation Coefficient, TDI0.9: A total deviation index of 0.9 (TDI 0.9) represents the distance (percentile)
that captures 90% of the differences in scores between the treating clinician and the patient. A TDI 0.9 of 0.7 means that in 90% of the cases the patient and
treating clinician score the patient status within 0.7 distance. CP0.4 Coverage Probability, proportion of cases within the Minimal Clinically Important difference
of 0.4.
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ment studies, only two clinicians participated in the
recruitment of the patients and the scoring of the CCQ,
as the main research question was the patient-reviewer
agreement. These two clinicians previously used the
CCQ in their practice or in pulmonary rehabilitation
programs. One clinician stated that he changed his his-
tory taking during the study, because he was unable to
answer specific questions on multiple occasions, espe-
cially about the mental state domain. The experience in
measuring health status and the change in history taking
might contribute to the high agreement between the
scores of the patient and treating clinician.
Conclusion
In conclusion, this study shows that this new method to
assess the individual validity of a questionnaire by using
patient interviews is feasible, and confirms results from
previous studies using statistical methods. Secondly,
there seems to be a good validity of the CCQ on the
individual patient level as established with this new
methods. The CCQ can therefore be used in routine
clinical practice to assess the health status of patients
with COPD.
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